NCCS joined with other organizations of the Cancer Leadership Council (CLC) in commenting on the FDA Biosimilar Action Plan (BAP). The comment letter commended the FDA for the development of a plan that balances both innovation and competition. The letter stated that these products provide significant benefits to cancer patients, but that they also come at a significant expense to patients and the health care system. […]
Make An Impact
The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.
Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action
- Get Involved
- COVID-19 Resources for Cancer Survivors
- Survivorship Checklist
- Cancer Survival Toolbox
- Cancer Convos Podcast
- Taking Charge of Your Care
- Care Planning for Cancer Survivors
- Tools For Care Providers
- Order Our Resources
- Contact Us
Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.